| # | Title | Journal | Year | Citations |
|---|
| 1 | Metformin: an old but still the best treatment for type 2 diabetes | Diabetology and Metabolic Syndrome | 2013 | 408 |
| 2 | Biochemical Study of Oxidative Stress Markers in the Liver, Kidney and Heart of High Fat Diet Induced Obesity in Rats | Diabetology and Metabolic Syndrome | 2011 | 340 |
| 3 | High plasma uric acid concentration: causes and consequences | Diabetology and Metabolic Syndrome | 2012 | 324 |
| 4 | NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology and Metabolic Syndrome | 2020 | 321 |
| 5 | Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis | Diabetology and Metabolic Syndrome | 2012 | 256 |
| 6 | Cardiovascular risk and obesity | Diabetology and Metabolic Syndrome | 2019 | 236 |
| 7 | Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis | Diabetology and Metabolic Syndrome | 2020 | 221 |
| 8 | The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis | Diabetology and Metabolic Syndrome | 2019 | 196 |
| 9 | Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases | Diabetology and Metabolic Syndrome | 2014 | 193 |
| 10 | Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study | Diabetology and Metabolic Syndrome | 2013 | 186 |
| 11 | Visceral adiposity, insulin resistance and cancer risk | Diabetology and Metabolic Syndrome | 2011 | 184 |
| 12 | Anxiety and depression among outpatients with type 2 diabetes: A multi-centre study of prevalence and associated factors | Diabetology and Metabolic Syndrome | 2010 | 182 |
| 13 | The effect of vitamin D on insulin resistance in patients with type 2 diabetes | Diabetology and Metabolic Syndrome | 2013 | 172 |
| 14 | The impact of sleep disorders on glucose metabolism: endocrine and molecular mechanisms | Diabetology and Metabolic Syndrome | 2015 | 164 |
| 15 | Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes | Diabetology and Metabolic Syndrome | 2016 | 154 |
| 16 | Cardiovascular risk assessment in patients with diabetes | Diabetology and Metabolic Syndrome | 2017 | 154 |
| 17 | The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States | Diabetology and Metabolic Syndrome | 2014 | 151 |
| 18 | Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance | Diabetology and Metabolic Syndrome | 2018 | 150 |
| 19 | Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice | Diabetology and Metabolic Syndrome | 2012 | 146 |
| 20 | Prevalence and gender distribution of the metabolic syndrome | Diabetology and Metabolic Syndrome | 2010 | 141 |
| 21 | Adverse pregnancy outcomes in women with diabetes | Diabetology and Metabolic Syndrome | 2012 | 140 |
| 22 | Mobile phone applications and their use in the self-management of Type 2 Diabetes Mellitus: a qualitative study among app users and non-app users | Diabetology and Metabolic Syndrome | 2019 | 127 |
| 23 | Mechanism of increased risk of insulin resistance in aging skeletal muscle | Diabetology and Metabolic Syndrome | 2020 | 127 |
| 24 | Link between insulin resistance and hypertension: What is the evidence from evolutionary biology? | Diabetology and Metabolic Syndrome | 2014 | 120 |
| 25 | Understanding diabetes in patients with HIV/AIDS | Diabetology and Metabolic Syndrome | 2011 | 119 |
| 26 | Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India | Diabetology and Metabolic Syndrome | 2017 | 119 |
| 27 | Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers | Diabetology and Metabolic Syndrome | 2013 | 118 |
| 28 | Shift work and its association with metabolic disorders | Diabetology and Metabolic Syndrome | 2015 | 118 |
| 29 | Visfatin, glucose metabolism and vascular disease: a review of evidence | Diabetology and Metabolic Syndrome | 2010 | 117 |
| 30 | Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus | Diabetology and Metabolic Syndrome | 2017 | 117 |
| 31 | Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management | Diabetology and Metabolic Syndrome | 2019 | 116 |
| 32 | Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats | Diabetology and Metabolic Syndrome | 2009 | 114 |
| 33 | Trace elements in glucometabolic disorders: an update | Diabetology and Metabolic Syndrome | 2010 | 114 |
| 34 | Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes | Diabetology and Metabolic Syndrome | 2013 | 112 |
| 35 | Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications | Diabetology and Metabolic Syndrome | 2017 | 112 |
| 36 | Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment | Diabetology and Metabolic Syndrome | 2010 | 111 |
| 37 | Interactions between kidney disease and diabetes: dangerous liaisons | Diabetology and Metabolic Syndrome | 2016 | 108 |
| 38 | Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review | Diabetology and Metabolic Syndrome | 2021 | 107 |
| 39 | Salivary uric acid as a noninvasive biomarker of metabolic syndrome | Diabetology and Metabolic Syndrome | 2012 | 103 |
| 40 | High prevalence of diabetes and intermediate hyperglycemia – The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) | Diabetology and Metabolic Syndrome | 2014 | 103 |
| 41 | Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial | Diabetology and Metabolic Syndrome | 2010 | 102 |
| 42 | Skin disorders in diabetes mellitus: an epidemiology and physiopathology review | Diabetology and Metabolic Syndrome | 2016 | 102 |
| 43 | Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis | Diabetology and Metabolic Syndrome | 2018 | 102 |
| 44 | Diabetic nephropathy | Diabetology and Metabolic Syndrome | 2009 | 101 |
| 45 | Construct validity of a continuous metabolic syndrome score in children | Diabetology and Metabolic Syndrome | 2010 | 101 |
| 46 | The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c | Diabetology and Metabolic Syndrome | 2014 | 100 |
| 47 | The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial | Diabetology and Metabolic Syndrome | 2019 | 99 |
| 48 | Diet-induced obesity in animal models: points to consider and influence on metabolic markers | Diabetology and Metabolic Syndrome | 2021 | 98 |
| 49 | Adipose tissue dysregulation and reduced insulin sensitivity in non-obese individuals with enlarged abdominal adipose cells | Diabetology and Metabolic Syndrome | 2012 | 97 |
| 50 | Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus | Diabetology and Metabolic Syndrome | 2015 | 97 |
